(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Inogen's Q2 Revenue Outlook Falls Short; UBS' Bullish Stance on Microsoft

July 14th, 2023

Inogen, Inc. (Nasdaq: INGN) issued a preliminary, unaudited financial update for the second quarter of 2023, revealing lower-than-expected revenue figures. The company estimates that total revenue for the quarter will fall within the range of $83 . Read more

Market Movers: JPMorgan and Wells Fargo Gain Momentum On Q2 Beat

July 14th, 2023

JPMorgan Chase & Co. (NYSE: JPM), a leading global financial services firm, delivered strong financial results in the second quarter of 2023, surpassing market expectations. The company reported adjusted earnings per share (EPS) of $4.37, outperformi. Read more

Downward Trend: Nokia's Revised Forecast, Ericsson's Q2 Losses

July 14th, 2023

Shares of Nokia Oyj (NYSE: NOK) experienced a significant decline in pre-market trading following the company's downward revision on its financial guidance for the full year 2023. The new net sales outlook for the year is expected to be in the ran. Read more

FDA Approves First Nonprescription Daily Oral Contraceptive

July 13th, 2023

Silver Spring, MD / CRWE PRESS RELEASE / July 13, 2023 -  Today, the U.S. Food and Drug Administration approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy— the first daily oral contraceptive approved for us. Read more

EHang Boosts UAM Presence; Bullish View On BioCryst Pharma

July 13th, 2023

EHang Holdings Limited (Nasdaq: EH) has partnered with the Bao'an District Government of Shenzhen municipality to advance urban air mobility (UAM) using EH216-S AAVs. The collaboration aims to develop UAM use cases, establish a demonstration center i. Read more

Negative Outlook Rattles Cryoport; Conagra's Profit View Misses the Mark

July 13th, 2023

Shares of Cryoport, Inc. (Nasdaq: CYRX) plummeted over 20% as the company presented a negative outlook for its upcoming financial results. Cryoport attributed the decline to weaker-than-expected global demand for capital equipment, delays in clinical. Read more

Ups and Downs: Strong Performance for Senmiao Tech, Fastenal's Q2 Misses

July 13th, 2023

Senmiao Technology Limited (Nasdaq: AIHS) announced its financial results for the full-year fiscal 2023, showcasing positive revenue growth and a significant reduction in net loss from continuing operations. The company reported total revenues of . Read more

Upbeat Earnings: PepsiCo and Delta Air Lines Beat Forecasts

July 13th, 2023

PepsiCo, Inc. (Nasdaq: PEP) reported strong financial results for the second quarter of fiscal 2023, surpassing market expectations. The company posted a core earnings per share (EPS) of $2.09, outperforming the consensus estimate of $1.96. Buildi. Read more

Breaking: Viasat Faces Challenges, UBS Bullish On Netflix

July 13th, 2023

Shares of Viasat, Inc. (Nasdaq: VSAT) experienced a significant drop of over 15% in the extended session after revealing an unexpected incident during the deployment of a reflector that could have a substantial impact on the performance of the ViaSat. Read more

CEO Contract Extension Boosts Walt Disney; MillerKnoll Q4 Earnings Beat, Outlook Disappoints

July 12th, 2023

Disney CEO Robert A. Iger's contract extension until December 31, 2026, propelled shares of The Walt Disney Company (NYSE: DIS) in after-hours trading.  The Board of Directors unanimously voted to extend Iger's tenure, emphasizing the need fo. Read more